Powerlifter receives sanction
Sport Integrity Australia acknowledges the decision of the National Sports Tribunal to sanction Para Powerlifter Cristine Ashcroft for the Presence, Use, Use and/or Attempted Use, and Possession of Prohibited Substances.
Ms Ashcroft returned an Adverse Analytical Finding (AAF) from an in-competition doping control test at the Australian National Para-Powerlifting Championships on 21 October 2017, a selection event for the 2018 Commonwealth Games. She also returned an AAF for an out-of-competition test on 21 February 2018.
The decision of the National Sports Tribunal confirmed that Ms Ashcroft committed the following Anti-Doping Rule Violations:
- Presence of a Prohibited Substance/s or its Metabolites or Markers, namely Exogenous Testosterone, Androsterone, Etiocholanolone and 5β-androstane-3α,17β-diol on 21 October 2017;
- Presence of a Prohibited Substance/s or its Metabolites or Markers, namely Exogeneous Androsterone, Etiocholanolone and 5βandrostane-3α,17β-diol on 21 February 2018;
- Use of a Prohibited Substance, namely Testosterone, on or about 3 August 2017 to on or about 21 February 2018;
- Possession of a Prohibited Substance, namely Testosterone, on or about 3 August 2017 to on or about 19 December 2017;
- Use and/or Attempted Use of a Prohibited Substance, namely Growth Hormone, on or about 23 September 2016 to on or about 30 September 2017; and
- Possession of a Prohibited Substance, namely Growth Hormone, on or about 23 September 2016 to on or about 30 September 2017.
Under category S1 of the World Anti-Doping Code Prohibited Lists 2017 and 2018, Androsterone, Etiocholanolone, 5β-androstane-3α,17β-diol, Testosterone and Growth Hormone are prohibited both in and out-of-competition.
The National Sports Tribunal imposed a 4-year ban on Ms Ashcroft; she will be eligible to return to competition on 21 March 2022.
Additional information on the prohibited substances
Anabolic agents pose many threats to an athlete’s health and some side effects may include an increase in blood pressure and cholesterol levels which can lead to heart disease. Liver disease and infertility can also result from the use of these agents.